Tokyo, Japan

Hidekazu Masuko


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hidekazu Masuko: A Pioneer in Anti-Hypertensive Compounds

Introduction

Hidekazu Masuko is a notable inventor based in Tokyo, Japan, recognized for his contribution to the field of pharmaceuticals. With a focus on innovative compounds, he has made significant strides in developing medications that address hypertension and enhance vasodilation.

Latest Patents

Masuko holds a patent for "Benzopyran derivatives having anti-hypertensive and vasodilatory" properties. This patent, which includes compounds of the specific formula that features trifluoromethyl and pentafluoroethyl groups, showcases his commitment to improving medical treatments for high blood pressure. His innovation is pivotal in the pharmaceutical domain, providing new avenues for effective treatment options.

Career Highlights

Masuko is associated with Sankyo Company, Limited, where he has utilized his expertise to advance research in anti-hypertensive drugs. His work has garnered him recognition in the industry, and he continues to contribute to the development of effective pharmaceutical solutions.

Collaborations

Throughout his career, Masuko has collaborated with esteemed colleagues such as Toshihiko Hashimoto and Hiroyuki Koike. These partnerships have enabled him to combine diverse expertise and foster innovative research, enhancing the overall quality of their contributions to the field.

Conclusion

Hidekazu Masuko exemplifies the spirit of innovation in the pharmaceutical industry. His patent on benzopyran derivatives not only highlights his ingenuity but also underscores the importance of collaboration in driving advancements in medical science. As he continues to work with his talented colleagues, the potential for future contributions remains promising and impactful.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…